Jin ES, Malloy CR, Sharma G, Finn E, Fuller KN, Reyes YG, et al
That alone should give legislators pause
The move from injectables to solid oral dose reflects a broader shift toward medicines that are easier to use, easier to scale and better suited to long-term patient needs
When you look at the overall cost of treating obesity with these medications, the numbers are staggering
Learn More About Natural GLP-1 Support Many people are curious about how nutrition and lifestyle compare with GLP-1 medications
However, the retrospective design carries inherent limitations